<TABLE> <S> <C>


<ARTICLE>         5
<LEGEND>
                  This schedule contains summary financial information extracted
                  from Rocky Point Pharmaceuticals, Inc. June 30, 2000 financial
                  statements  and is  qualified  in its entirety by reference to
                  such financial statements.
</LEGEND>

<CIK>                         0000853465
<NAME>                        Rocky Point Pharmaceuticals, Inc.
<CURRENCY>                    US



<S>                           <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-END>                  JUN-30-2000
<EXCHANGE-RATE>               1.00

<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 0
<CURRENT-LIABILITIES>                          0
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       1,000
<OTHER-SE>                                     (1,000)
<TOTAL-LIABILITY-AND-EQUITY>                   0
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                0
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   0
<EPS-BASIC>                                    .00
<EPS-DILUTED>                                  .00



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission